What does CUSIP 56854Q101 represent in this 13F holders report?

CUSIP 56854Q101 is the security identifier for MRNS - MARINUS PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held MRNS - MARINUS PHARMACEUTICALS INC - COM in Q1 2017?

24 institutional investors reported MRNS - MARINUS PHARMACEUTICALS INC - COM for Q1 2017. Use the holders table for investor-level position and value details.

MARINUS PHARMACEUTICALS INC - COM (MRNS)

CUSIP: 56854Q101

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / COM
Total 13F shares: 7,327,447
Share change: +2,616,053
Total reported value: $12,970,000
Price per share: $1.77
Number of holders: 24
Value change: +$4,638,615
Number of buys: 12
Number of sells: 8

Quarterly Holders Quick Answers

What is CUSIP 56854Q101?
CUSIP 56854Q101 identifies MRNS - MARINUS PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 56854Q101:

Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019

Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q1 2017

As of 31 Mar 2017, MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,327,447 shares. The largest 10 holders included FRANKLIN RESOURCES INC, SPHERA FUNDS MANAGEMENT LTD., NEXTHERA CAPITAL LP, Granite Point Capital Management, L.P., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, JENNISON ASSOCIATES LLC, BlackRock Inc., KCG HOLDINGS, INC., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.